Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches

2015 ◽  
Vol 9 (3) ◽  
pp. 351-359
Author(s):  
Emmanuel Androulakis ◽  
Eirini Lioudaki ◽  
Theodoros Christophides ◽  
Mahmood Ahmad ◽  
Hossam Fayed ◽  
...  
2019 ◽  
Vol 28 (02) ◽  
pp. 112-117
Author(s):  
Sanjay Tyagi ◽  
Vishal Batra

AbstractPulmonary arterial hypertension (PAH) is an uncommon disease characterized progressive remodeling of pulmonary vasculature. Although treatment for PAH have improved in last two decades but the outcome remains fatal. Currently, the therapies for PAH target three well-established pathways the nitric oxide (NO) pathway, endothelin receptors, and prostanoids. There are multiple potential targets for development of newer drugs in PAH which requires meticulous research and clinical trials.


Thorax ◽  
2011 ◽  
Vol 66 (Suppl 4) ◽  
pp. A3-A3
Author(s):  
A. G. Hameed ◽  
N. D. Arnold ◽  
J. Pickworth ◽  
J. C. Chamberlain ◽  
C. M. H. Newman ◽  
...  

The Lancet ◽  
2013 ◽  
Vol 381 ◽  
pp. S47
Author(s):  
Abdul G Hameed ◽  
Nadine D Arnold ◽  
Janet Chamberlain ◽  
Josephine A Pickworth ◽  
Claudia Paiva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document